Scientists Argue that this Genetic Test’s Results are “no better than a coin flip.” The FDA approved it anyway.

Recently, the FDA approved a genetic test for opioid use disorder despite clear opposition from scientists and the FDA advisory panel that had reviewed the evidence. The case demonstrates the space where Pharma’s incentive may drive innovation that may not help–or worse, cause harm. Abdul reflects on how genetic essentialism and the wrong incentives can reinforce each other. Than he speaks with Dr. Elizabeth Joniak-Grant, a sociologist and patient advocate who voted against the genetic test.This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by:Marguerite Casey Foundation invites you to sign up for their new Summer School program at caseygrants.org/summerschool.Henson Shaving invites you to find the razor that will last you a lifetime. Go to https://hensonshaving.com and enter AD at checkout to get 100 free blades with your purchase. (Note: you must add both the 100-blade pack and the razor for the discount to apply.)Blueland invites you to celebrate Plastic Free July with up to 25% off your Blueland order. Go to Blueland.com/america now for your special limited time offer.